Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptions

Allergan plc News

Glaxo Rises as Elliott Takes Hefty Stake in Drugmaker

The size of Elliott's stake in Glaxo wasn't disclosed. Elliott is headed by iconic investor Paul Singer. Glaxo's shares rose.

AbbVie Reportedly Plans to Sell $5 Billion Women's Drugs Unit

AbbVie is in talks to sell its women's drug business, which makes the Lo Loestrin Fe birth control pill, in an auction, according to Reuters.

Amazon Is Clearly What Hedge Funds Are Betting On These Days

Amazon is perhaps the ultimate all-weather company, and hedge funds have poured into the stock.

AbbVie Is a Buy as Allergan Deal Closes - A Look at the Charts

AbbVie is rallying now that the company has closed its mega-deal with Allergan. The stock is looking to possibly test 2020 highs.

Stock Market Today With Jim Cramer: Oil Prices Go Negative

Jim Cramer discusses the stock market today including the collapse of the oil market, the cannabis stock sector and AbbVie potentially trending up.

Breaking News

BP Among Leaders of Fair Value Increases by Morningstar

In the energy sector, 25% of the companies covered by Morningstar garnered fair-value increases of more than 10%.

How to Purge Gun Stocks From Your 401(k)

After mass shootings, a lot of investors are saying enough if enough.

Nvidia Stock: Investors Are Buying the Dip. Where From Here?

Nvidia stock is being bought on the dip. Here's how traders should approach it now.

Broadcom Agrees to Buy VMware in $61 Billion Cash-and-Stock Cloud Software Deal

"Combining our assets and talented team with Broadcom's existing enterprise software portfolio creates a remarkable enterprise software player," said VMware CEO Raghu Raghuram.